This is mostly characterized by the swelling and inflammation of the synovial membrane - thereby causing severe pain and stiffness in the joints of the victims. Inflammatory arthritis makes the joint look red and warm when touched. Arthritis relief for victims is necessary to reduce the pain.
Arthritis relief is therefore very important, especially in a country like the United States where Arthritis is the number one cause of physical disability. There are an estimated total number of 43 million Americans - 16 percent of the population, suffering from one form of arthritis or the other.
It is not only adults who need arthritis relief, but also children. In the United States, about 300,000 children suffer from one type of arthritis related disease or another. Children, being very susceptible to pain, need arthritis relief and treatment more than ever before. Unlike adults who can endure joint pains to a great degree, children cannot and therefore need arthritis relief as soon as the problem starts.
About the Author :
“Want to Discover 4 Pain relief Secrets?” Arthritis Doctor - Arthritis Symptom - Relief From Arthritis Pain Source: www.isnare.com
Written By: Jeff Jefferson

Medication fears lead to worse side effects - Vancouver Sun
NEW YORK - It may not be surprising, but a new study offers some proof that patients who are worried about their medications are more likely to have side effects from them. The study involved patients with a particular kind of arthritis. While more ...
Roche, Biogen Suspend Arthritis Drug Program After Patient Deaths - Daily Finance
An independent safety monitoring board recommended the pharmaceutical firms halt the program after concluding that the safety risks outweighed the benefits observed in some patients. Specifically, the board detected "serious and opportunistic ...
UPDATE 2-Roche suspends arthritis treatment after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S.-listed Biogen Idec ( BIIB.O ) are suspending rheumatoid arthritis and lupus treatment ocrelizumab after it caused deaths, casting doubt over the drug's future. Roche and ...
UPDATE 4-Roche, Biogen suspends arthritis drug after deaths - Reuters
ZURICH, March 8 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) and U.S. biotechnology company Biogen Idec ( BIIB.O ) are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting ...
Roche, Biogen Idec Suspend Tests for Arthritis Drug (Update3) - BusinessWeek
March 8 (Bloomberg) -- Roche Holding AG and Biogen Idec Inc. are suspending development of the ocrelizumab treatment for use in arthritis after an independent monitoring board said safety risks outweigh benefits observed in these patients. The ...
Roche, Biogen suffer setback with rheumatoid arthritis drug - Marketwatch
ZURICH (MarketWatch) -- Roche Holding AG (ROG.VX) and Biogen Idec Inc (NASDAQ:BIIB) said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market ...
Major Pharmaceutical Company Stops Arthritis Study After Deaths - FOX News
Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. Roche said the drug, ocrelizumab, was developed together with Biogen ...